You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API QUAZEPAM

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing QUAZEPAM

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Galt Pharmaceuticals LLC	DORAL	quazepam	61825-165	FD&C YELLOW NO. 6	2028-06-03
Galt Pharmaceuticals LLC	DORAL	quazepam	61825-165	LACTOSE	2028-06-03
Galt Pharmaceuticals LLC	DORAL	quazepam	61825-165	MAGNESIUM STEARATE	2028-06-03
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for QUAZEPAM

Excipient focus: FD&C YELLOW NO. 6

QUAZEPAM drug variants containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE

QUAZEPAM drug variants containing LACTOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing LACTOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

QUAZEPAM drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POWDERED CELLULOSE

QUAZEPAM drug variants containing POWDERED CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing POWDERED CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

QUAZEPAM drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM LAURYL SULFATE

QUAZEPAM drug variants containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STARCH, CORN

QUAZEPAM drug variants containing STARCH, CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Galt Pharmaceuticals LLC	quazepam	61825-165
Atland Pharmaceuticals LLC	quazepam	71993-265
>Company	>Ingredient	>NDC

QUAZEPAM drug variants not containing STARCH, CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.